Immunoreactivity | Monoclonality | |||||||
---|---|---|---|---|---|---|---|---|
No. | MPO/Lys | TdT | CD10/CD20/CD79a | CD3/βF1 | IgH | TCR-γ | Primary diagnosis | Probable lineage on the basis of PCR |
Cases were recorded as immunoreactive if more than 10% of the blast cells were positive. AL, acute leukaemia; ALL, acute lymphoblastic leukaemia; AML, acute myelogenous leukaemia; B-ALL, B cell ALL; IgH, immunoglobulin heavy chain; MPO, myeloperoxidase; Lys, lysozyme; PCR, polymerase chain reation; T-ALL, T cell ALL; TCR-γ, T cell receptor γ, TdT, terminal deoxynucleotidyl transferase; u-ALL, unclassified ALL. | ||||||||
1 | CD10/CD20 | + | c-ALL | |||||
2 | CD10/CD20 | βF1 | + | c-ALL | ||||
3 | CD10 | + | c-ALL | |||||
4 | TdT | CD10 | + | c-ALL | ||||
5 | TdT | CD10/CD79a | + | c-ALL | ||||
6 | TdT | CD10/CD79a | βF1 | + | c-ALL | |||
7 | TdT | CD10 | βF1 | + | c-ALL | |||
8 | TdT | CD10/CD79a | + | + | c-ALL | ALL, bilinear genotype? | ||
9 | TdT | CD10/CD20 | + | c-ALL | ||||
10 | TdT | CD10/CD79a | CD3 | c-ALL | ||||
11 | TdT | CD10/CD79a | + | c-ALL | ||||
12 | TdT | CD10/CD20 | + | c-ALL | ||||
13 | TdT | CD10/CD79a | + | c-ALL | ||||
14 | TdT | CD10/CD79a | + | c-ALL | ||||
15 | TdT | CD10/CD79a | + | c-ALL | ||||
16 | TdT | CD10/CD79a | + | c-ALL | ||||
17 | CD10/CD20 | + | c-ALL | |||||
18 | TdT | CD10 | + | c-ALL | T-ALL | |||
19 | CD10 | CD3/βF1 | c-ALL | |||||
20 | TdT | CD10/CD20/CD79a | βF1 | + | c-ALL | |||
21 | TdT | CD10/CD79a | + | c-ALL | ||||
22 | TdT | CD10 | + | c-ALL | ||||
23 | TdT | CD10/CD79a | + | c-ALL | ||||
24 | CD3/βF1 | + | T-ALL | |||||
25 | TdT | βF1 | + | T-ALL | ||||
26 | TdT | CD3 | T-ALL | |||||
27 | TdT | βF1 | T-ALL | |||||
28 | TdT | βF1 | + | T-ALL | ||||
29 | + | T-ALL | ||||||
30 | TdT | βF1 | + | T-ALL | ALL, B cell genotype? | |||
31 | CD20/CD79a | + | B-ALL | |||||
32 | CD20/CD79a | CD3 | + | u-ALL | ALL, B cell genotype | |||
33 | + | u-ALL | ALL, B cell genotype | |||||
34 | CD20 | + | u-ALL | ALL, B cell genotype | ||||
35 | TdT | + | + | u-ALL | ALL, bilinear genotype | |||
36 | MPO | TdT | + | AL, biphenotypic | ||||
37 | MPO | CD20 | βF1 | AL, biphenotypic | ||||
38 | MPO | TdT | CD79a | + | AL, biphenotypic | B cell type | ||
39 | MPO | + | AML-M1 | B cell genotype? | ||||
40 | MPO | AML-M1 | ||||||
41 | MPO | AML-M1 | ||||||
42 | MPO | AML-M1 | ||||||
43 | MPO/Lys | AML-M4 | ||||||
44 | MPO/Lys | AML-M4 | ||||||
45 | MPO | AML-M4 | ||||||
46 | MPO | AML-M4 | ||||||
47 | MPO | AML-M4 | ||||||
48 | MPO/Lys | + | AML-M5 | B-cell genotype ? |